Camp4 Therapeutics (CAMP) Amortizatization of Intangibles (2024 - 2026)
Camp4 Therapeutics' (CAMP) quarterly Amortizatization of Intangibles came in at $34000.0 in Q1 2026, down 92.84% year-on-year from $475000.0 in Q1 2025, and down 92.92% quarter-over-quarter from $480000.0 in Q4 2025.
Camp4 Therapeutics (CAMP) Amortizatization of Intangibles (2024 - 2026) Analysis & Trends
Camp4 Therapeutics has disclosed Amortizatization of Intangibles across 3 years of filings, most recently posting $34000.0 for Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $34000.0, down 92.84% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.5 million (down 18.62% YoY), and the FY2025 annual result was $1.9 million, up 9.95% from the prior year.
- Amortizatization of Intangibles came in at $34000.0 for Q1 2026 at Camp4 Therapeutics, down from $480000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $489000.0 in Q3 2025 to a low of $34000.0 in Q1 2026.
- The 3-year median for Amortizatization of Intangibles is $464000.0 (2024), against an average of $411777.8.
- Across the five-year window, Amortizatization of Intangibles gained 17.87% in 2025 and plunged 92.84% in 2026, its largest moves.
- Camp4 Therapeutics' Amortizatization of Intangibles stood at $464000.0 in 2024, then advanced by 3.45% to $480000.0 in 2025, then slumped by 92.92% to $34000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $34000.0 (Q1 2026), $480000.0 (Q4 2025), and $489000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Camp4 Therapeutics | 245.02 Mn | 245.02 Mn | - | 34,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34,000.00 |
| Mar 31, 2026 | 34,000.00 |
| Dec 31, 2025 | 480,000.00 |
| Dec 31, 2025 | 480,000.00 |
| Sep 30, 2025 | 489,000.00 |
| Sep 30, 2025 | 489,000.00 |
| Jun 30, 2025 | 479,000.00 |
| Jun 30, 2025 | 479,000.00 |
| Mar 31, 2025 | 475,000.00 |
| Mar 31, 2025 | 475,000.00 |
| Dec 31, 2024 | 464,000.00 |
| Dec 31, 2024 | 464,000.00 |
| Sep 30, 2024 | 450,000.00 |
| Sep 30, 2024 | 450,000.00 |
| Jun 30, 2024 | 432,000.00 |
| Jun 30, 2024 | 432,000.00 |
| Mar 31, 2024 | 403,000.00 |
| Mar 31, 2024 | 403,000.00 |